Alerts will be sent to your verified email
Verify EmailBANDARAM
|
Bandaram Pharma Pack
|
Vilin Bio Med
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.64 % | 3.09 % | -8.32 % |
|
5yr average Equity Multiplier
|
4.09 | 1.6 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.98 | 0.68 | 0.77 |
|
5yr Avg Net Profit Margin
|
1.46 % | 2.8 % | -8.22 % |
|
Price to Book
|
3.59 | 2.12 | 0.82 |
|
P/E
|
228.0 | 218.77 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
185.52 Days | 211.9 Days | 11.27 Days |
|
Inventory Days
|
58.64 Days | 70.76 Days | 46.83 Days |
|
Days Receivable
|
164.3 Days | 147.75 Days | 10.61 Days |
|
Days Payable
|
29.07 Days | 44.01 Days | 83.41 Days |
|
5yr Average Interest Coverage Ratio
|
2.12 | 1.77 | -18.91 |
|
5yr Avg ROCE
|
8.53 % | 8.99 % | 1.03 % |
|
5yr Avg Operating Profit Margin
|
7.35 % | 9.07 % | 9.99 % |
|
5 yr average Debt to Equity
|
2.33 | 0.47 | 0.2 |
|
5yr CAGR Net Profit
|
16.17 % | 12.89 % | n/a |
|
5yr Average Return on Assets
|
1.43 % | 1.89 % | -5.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.62 % | 63.65 % | 53.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 20.66 % |
|
Change in Promoter Holding (3 Yrs)
|
-12.38 % | -0.87 % | 9.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bandaram Pharma Pack
|
Vilin Bio Med
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|